Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Inspire Medical Systems, Inc. or Enovis Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Inspire Medical Systems, Inc. and Enovis Corporation compare based on key financial metrics to determine which better meets your investment needs.

About Inspire Medical Systems, Inc. and Enovis Corporation

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

Latest Health Care Equipment & Supplies and Inspire Medical Systems, Inc., Enovis Corporation Stock News

As of September 8, 2026, Inspire Medical Systems, Inc. had a $1.8 billion market capitalization, compared to the Health Care Equipment & Supplies median of $415.8 million. Inspire Medical Systems, Inc.’s stock is down 32.6% in 2026, down 1.3% in the previous five trading days and down 28.13% in the past year.

Currently, Inspire Medical Systems, Inc.’s price-earnings ratio is 13.5. Inspire Medical Systems, Inc.’s trailing 12-month revenue is $898.7 million with a 15.0% net profit margin. Year-over-year quarterly sales growth most recently was -7.6%. Analysts expect adjusted earnings to reach $1.247 per share for the current fiscal year. Inspire Medical Systems, Inc. does not currently pay a dividend.

As of September 8, 2026, Enovis Corporation had a $1.2 billion market cap, putting it in the 46th percentile of all stocks. Enovis Corporation’s stock is down 25% in 2026, down 18.7% in the previous five trading days and down 37.82% in the past year.

Currently, Enovis Corporation does not have a price-earnings ratio. Enovis Corporation’s trailing 12-month revenue is $2.3 billion with a -48.0% net profit margin. Year-over-year quarterly sales growth most recently was 3.2%. Analysts expect adjusted earnings to reach $3.640 per share for the current fiscal year. Enovis Corporation does not currently pay a dividend.

How We Compare Inspire Medical Systems, Inc. and Enovis Corporation Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Inspire Medical Systems, Inc. and Enovis Corporation’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Inspire Medical Systems, Inc. and Enovis Corporation Growth Grades

Company	Ticker	Growth
Inspire Medical Systems, Inc.	INSP	D
Enovis Corporation	ENOV	C

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Inspire Medical Systems, Inc. has a Growth Score of 40, which is Weak. Enovis Corporation has a Growth Score of 60, which is Average.

The Growth Stock Winner: No Clear Winner

Neither Inspire Medical Systems, Inc. or Enovis Corporation has a high enough Growth Grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Inspire Medical Systems, Inc. or Enovis Corporation is the better investment when it comes to sustainable growth.

Inspire Medical Systems, Inc. and Enovis Corporation’s Momentum Grades

Company	Ticker	Momentum
Inspire Medical Systems, Inc.	INSP	A
Enovis Corporation	ENOV	F

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Inspire Medical Systems, Inc. has a Momentum Score of 81, which is Very Strong. Enovis Corporation has a Momentum Score of 16, which is Very Weak.

The Momentum Grade Winner: Inspire Medical Systems, Inc.

As you can clearly see from the Momentum Grade breakdown above, Inspire Medical Systems, Inc. is considered to have stronger momentum compared to Enovis Corporation. For those specifically looking for companies that have stronger momentum compared to other companies in the same industry, Inspire Medical Systems, Inc. could be a good stock to invest in. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Inspire Medical Systems, Inc. and Enovis Corporation’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Inspire Medical Systems, Inc.	INSP	B
Enovis Corporation	ENOV	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Inspire Medical Systems, Inc. has a Earnings Estimate Score of 72, which is Positive. Enovis Corporation has a Earnings Estimate Score of 58, which is Neutral.

The Earnings Estimate Revisions Grade Winner: Inspire Medical Systems, Inc.

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Inspire Medical Systems, Inc. has a better Earnings Estimate Revisions Grade than Enovis Corporation. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Inspire Medical Systems, Inc. could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Inspire Medical Systems, Inc. and Enovis Corporation Grades

In addition to Growth, Estimate Revisions and Momentum, A+ Investor also provides grades for Value and Quality.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Inspire Medical Systems, Inc. and Enovis Corporation pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Inspire Medical Systems, Inc. or Enovis Corporation Stock?

Overall, Inspire Medical Systems, Inc. stock has a Growth Score of 40, Momentum Score of 81 and Estimate Revisions Score of 72.

Enovis Corporation stock has a Growth Score of 60, Momentum Score of 16 and Estimate Revisions Score of 58.

Comparing Inspire Medical Systems, Inc. and Enovis Corporation’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.